Passive In-Line Chlorination for Drinking Water Disinfection: A Critical Review.
Megan Lindmark, Katya Cherukumilli, Yoshika S Crider...
https://pubmed.ncbi.nlm.nih.gov/35700262Actively Recruiting
Led by University of California, Berkeley · Updated on 2025-05-25
45450
Participants Needed
2
Research Sites
N/A
Total Duration
U
University of California, Berkeley
Lead Sponsor
N
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborating Sponsor
This research aims to evaluate the effects of a multi-component chlorination intervention on maternal and neonatal health in public healthcare facilities in western Kenya. The trial focuses on reducing bacterial contamination and antibiotic-resistant infections in neonates born at these facilities. The study is a cluster randomized controlled trial involving 36 health facilities, with a goal to provide evidence on how chlorinated water supply and reliable chlorine disinfectant use impact bacterial contamination and infection rates. Health facilities will be randomly assigned either to a control group or to an intervention group. Intervention facilities will receive passive inline chlorine dosers that automatically treat water used in maternity wards, along with a steady supply of chlorine disinfectant. Half of the intervention sites will produce chlorine on-site using electrochlorinators, while the other half will receive bulk chlorine deliveries. Both intervention and control facilities will receive infection prevention and control messaging. Facilities will also get equipment like mops and spray bottles for surface cleaning. Participants include pregnant adults or mature minors giving birth at enrolled facilities and their newborns. Researchers will collect data over 24 months, assessing bacterial contamination in water, on hands, and on surfaces, as well as gut colonization by pathogenic and antibiotic-resistant bacteria in mothers and neonates. Health outcomes like possible serious bacterial infection and sepsis symptoms will be monitored during the first week after birth. The study will also track neonatal and maternal mortality up to 28 days postpartum to understand the intervention's impact on infection and health.
CONDITIONS
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Pregnant adults or mature minors arriving at enrolled facilities to give birth are assessed for eligibility.
Duration - 24 months
Participants experience the installation and use of inline chlorine dosers for automated water disinfection and surface disinfection at the health facilities. Intervention includes infection prevention and control messaging.
Ongoing monitoring visits at health facilities throughout the study duration.
Duration - 7 days post birth
Participants (mothers and neonates) are followed for symptoms of possible serious bacterial infection and colonization by bacterial pathogens in the week following birth.
Follow-up visits or assessments occur during the first week after birth.
Total: 2 locations
1
University of California, Berkeley
Berkeley, California, United States, 94720
Active, Not Recruiting
2
Kenya Medical Research Institute
Nairobi, Kenya
Actively Recruiting
A
Amy J Pickering, PhD
Y
Yoshika Crider, PhD
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Megan Lindmark, Katya Cherukumilli, Yoshika S Crider...
https://pubmed.ncbi.nlm.nih.gov/35700262Amy J Pickering, Yoshika Crider, Sonia Sultana...
https://pubmed.ncbi.nlm.nih.gov/31402005